These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

789 related items for PubMed ID: 1698544

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effects of human prostatic mitogens on rat bone cells and fibroblasts.
    Koutsilieris M, Rabbani SA, Goltzman D.
    J Endocrinol; 1987 Dec; 115(3):447-54. PubMed ID: 2450942
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Secretory products of breast cancer cells specifically affect human osteoblastic cells: partial characterization of active factors.
    Siwek B, Lacroix M, De Pollak C, Marie P, Body JJ.
    J Bone Miner Res; 1997 Apr; 12(4):552-60. PubMed ID: 9101366
    [Abstract] [Full Text] [Related]

  • 7. Growth factors mediate glucocorticoid receptor function and dexamethasone-induced regression of osteoblastic lesions in hormone refractory prostate cancer.
    Koutsilieris M, Reyes-Moreno C, Sourla A, Dimitriadou V, Choki I.
    Anticancer Res; 1997 Apr; 17(3A):1461-5. PubMed ID: 9179184
    [Abstract] [Full Text] [Related]

  • 8. Cellular and molecular effects of growth hormone and estrogen on human bone cells.
    Kassem M.
    APMIS Suppl; 1997 Apr; 71():1-30. PubMed ID: 9357492
    [Abstract] [Full Text] [Related]

  • 9. A proteome study of secreted prostatic factors affecting osteoblastic activity: galectin-1 is involved in differentiation of human bone marrow stromal cells.
    Andersen H, Jensen ON, Moiseeva EP, Eriksen EF.
    J Bone Miner Res; 2003 Feb; 18(2):195-203. PubMed ID: 12568396
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Human bone cell phenotypes differ depending on their skeletal site of origin.
    Kasperk C, Wergedal J, Strong D, Farley J, Wangerin K, Gropp H, Ziegler R, Baylink DJ.
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2511-7. PubMed ID: 7629252
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Selective osteoblast mitogens can be extracted from prostatic tissue.
    Koutsilieris M, Rabbani SA, Goltzman D.
    Prostate; 1986 Aug; 9(2):109-15. PubMed ID: 2428019
    [Abstract] [Full Text] [Related]

  • 14. Insulin-like growth factor (IGF)-I, -II, IGF binding proteins (IGFBP)-3, -4, and -5 levels in the conditioned media of normal human bone cells are skeletal site-dependent.
    Malpe R, Baylink DJ, Linkhart TA, Wergedal JE, Mohan S.
    J Bone Miner Res; 1997 Mar; 12(3):423-30. PubMed ID: 9076585
    [Abstract] [Full Text] [Related]

  • 15. Prostate cancer cells-osteoblast interaction shifts expression of growth/survival-related genes in prostate cancer and reduces expression of osteoprotegerin in osteoblasts.
    Fizazi K, Yang J, Peleg S, Sikes CR, Kreimann EL, Daliani D, Olive M, Raymond KA, Janus TJ, Logothetis CJ, Karsenty G, Navone NM.
    Clin Cancer Res; 2003 Jul; 9(7):2587-97. PubMed ID: 12855635
    [Abstract] [Full Text] [Related]

  • 16. Growth factors secreted by the GH3 rat pituitary tumor cell line. Study of their autocrine mitogenic activity in cultured GH3 cells, A431 cells and human fibroblasts.
    Constantinescu I.
    Rom J Endocrinol; 1993 Jul; 31(1-2):27-39. PubMed ID: 8173571
    [Abstract] [Full Text] [Related]

  • 17. Urokinase-type plasminogen activator: a paracrine factor regulating the bioavailability of IGFs in PA-III cell-induced osteoblastic metastases.
    Koutsilieris M, Frenette G, Lazure C, Lehoux JG, Govindan MV, Polychronakos C.
    Anticancer Res; 1993 Jul; 13(2):481-6. PubMed ID: 7685989
    [Abstract] [Full Text] [Related]

  • 18. CDGF (chicken embryo fibroblast-derived growth factor) is mitogenically related to TGF-beta and modulates PDGF, bFGF, and IGF-I action on sparse NIH/3T3 cells.
    Geistlich A, Gehring H.
    Exp Cell Res; 1993 Feb; 204(2):329-35. PubMed ID: 8440329
    [Abstract] [Full Text] [Related]

  • 19. Prostate cancer cells induce osteoblast differentiation through a Cbfa1-dependent pathway.
    Yang J, Fizazi K, Peleg S, Sikes CR, Raymond AK, Jamal N, Hu M, Olive M, Martinez LA, Wood CG, Logothetis CJ, Karsenty G, Navone NM.
    Cancer Res; 2001 Jul 15; 61(14):5652-9. PubMed ID: 11454720
    [Abstract] [Full Text] [Related]

  • 20. Beta 2-microglobulin is not a bone cell mitogen.
    Jennings JC, Mohan S, Baylink DJ.
    Endocrinology; 1989 Jul 15; 125(1):404-9. PubMed ID: 2661210
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.